Maprotiline Hydrochloride (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Maprotiline Hydrochloride drug offered from Mylan Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: maprotiline hydrochloride
SUBSTANCE NAME: MAPROTILINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1988-10-03
END MARKETING DATE: 0000-00-00


Maprotiline Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMaprotiline Hydrochloride from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 1988-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-0060_8ab0b141-aa2a-4329-a77c-da427e79fc39
PRODUCT NDC: 0378-0060
APPLICATION NUMBER: ANDA072285

Other MAPROTILINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Pharmaceuticals Inc.Maprotiline Hydrochloride